STABILITY-INDICATING RP-HPLC METHOD FOR ANALYSIS OF ATORVASTATIN IN BULK DRUG, MARKETED TABLET AND NANOEMULSION FORMULATION

被引：0

作者：

Mustafa, Gulam ^{[1
]}

Azeem, Adnan ^{[1
]}

Ahmad, Farhan J. ^{[1
]}

Khan, Zeenat I. ^{[1
]}

Shakeel, Faiyaz ^{[2
]}

Talegaonkar, Sushma ^{[1
]}

机构：

[1] Fac Pharm, Dept Pharmaceut, New Delhi 110062, India

[2] Al Arab Med Univ, Fac Pharm, Dept Pharmaceut, Benghazi, Libya

来源：

JOURNAL OF THE CHILEAN CHEMICAL SOCIETY | 2010年 / 55卷 / 02期

关键词：

RP-HPLC; atorvastatin; nanoemulsion; tablets; ICH guidelines; PERFORMANCE LIQUID-CHROMATOGRAPHY; HUMAN PLASMA; HUMAN SERUM; VALIDATION; ASSAY; UV; QUANTITATION; AMLODIPINE; CALCIUM;

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

A simple, highly sensitive, isocratic stability indicating reversed phase-high performance liquid chromatography (RP-HPLC) method with UV detection at 247 nm was developed and validated for analysis of atorvastatin (AT). Retention time of the AT was found to be 4.02 min. A mobile phase consisting of 0.05 M sodium phosphate buffer and methanol (3:7 v/v) pH 4.1 at flow rate of 1 mL/min was employed in this study. The calibration curves were linear with regression coefficient (r(2)) of 0.9997 +/- 0.0014. The limits of detection (LOD) and the limits of quantification (LOQ) were found to be 0.20 and 0.60 mu g/mL, respectively. The method was statistically validated in accordance with International conference on harmonization (ICH) guidelines. The proposed method was found sensitive, specific and was successfully applied for the estimation of atorvastatin in pharmaceutical formulations (bulk drug, tablet, nanoemulsion).

引用

页码：184 / 188

页数：5

共 32 条

[1] Liquid chromatographic determination of atorvastatin in bulk drug, tablets, and human plasma
Altuntas, TG
Erk, N
[J]. JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2004, 27 (01) : 83 - 93
[2] Determination of atorvastatin in human serum by reversed-phase high-performance liquid chromatography with UV detection
Bahrami, G
Mohammadi, B
Mirzaeei, S
Kiani, A
[J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 826 (1-2): : 41 - 45
[3] Validated HPLC-MS-MS method for simultaneous determination of atorvastatin and 2-hydroxyatorvastatin in human plasma -: pharmacokinetic study
Borek-Dohalsky, V.
Huclova, J.
Barrett, B.
Nemec, B.
Ulc, I.
Jelinek, I.
[J]. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2006, 386 (02) : 275 - 285
[4] Development and validation of a high-performance liquid chromatography tandem mass spectrometry assay for atorvastatin, ortho-hydroxy atorvastatin, and para-hydroxy atorvastatin in human, dog, and rat plasma
Bullen, WW
Miller, RA
Hayes, RN
[J]. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 1999, 10 (01) : 55 - 66
[5] Stability indicating RP-HPLC method for simultaneous determination of atorvastatin and amlodipine from their combination drug products
Chaudhari, Bharat Ganeshbhai
Patel, Natvarlal Manilal
Shah, Paresh Bhagvatiprasad
[J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 2007, 55 (02) : 241 - 246
[6] Extractive spectrophotometric determination of atorvastatin in bulk and pharmaceutical formulations
Erk, N
[J]. ANALYTICAL LETTERS, 2003, 36 (12) : 2699 - 2711
[7] An HPLC method for the determination of atorvastatin and its impurities in bulk drug and tablets
Ertürk, S
Aktas, ES
Ersoy, L
Fiçicioglu, S
[J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 33 (05) : 1017 - 1023
[8] Determination of atorvastatin and metabolites in human plasma with solid-phase extraction followed by LC-tandem MS
Hermann, M
Christensen, H
Reubsaet, JLE
[J]. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2005, 382 (05) : 1242 - 1249
[9] *ICH STEER COMM IF, 1996, INT C HARM ICH TECHN
[10] Ismail, 2008, ASIAN J RES CHEM, V1, P40

← 1 2 3 4 →